Summary
The urinary excretion of amitriptyline (AMT) and seven of its metabolites was studied by mass spectrometry in 10 depressive in-patients treated to steady-state condition with oral amitriptyline. An average of 68.3% of the dose was recovered in the urine, of which 68.6% was present as conjugates. Hydroxynortriptyline and its conjugate represented 54% of the total recovery. There was marked variation in metabolite pattern between patients. The variations were not due to concomitant medication with benzodiazepines. There was no correlation between the plasma and urine concentrations of AMT and its metabolites, except for amitriptyline conjugates. Two groups of patients could be distinguished — low and high excretors, who displayed alternative routes of metabolism. The disappearance rate of AMT from plasma was determined by the metabolic clearance of AMT to its metabolites. It varied considerably between patients.
Similar content being viewed by others
References
Amundson ME, Manthey JA (1966) Excretion of nortriptyline hydrochloride in man. I. Detection and determination of urinary nortriptyline. J Pharm Sci 55: 277–280
Åsberg M, Cronholm B, Sjöqvist F, Tuck D (1971b) Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3: 331–334
Alexanderson B, Borgå O (1973) A quantitative study of nortriptyline and five of its metabolites in human urine after oral administration of single and multiple dose. Eur J Clin Pharmacol 5: 174–180
Bahr C von (1972) Binding and oxidation of amitriptyline and a series of its oxidized metabolites in liver microsomes from untreated and phenobarbital-treated rats. Xenobiotica 2: 293–306
Bertilsson L, Alexanderson B (1972) Stereospecific hydroxylation of nortriptyline in man in relation to interindividual differences in its steady state plasma level. Eur J Clin Pharmacol 4: 201–205
Bertilsson I, Eichelbaum M, Mellström B, Sawe J, Schulz HU, Sjöqvist F (1980) Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. Life Sci 27: 1673–1677
Bickel MH, Flückiger M, Baggiolini M (1967 a) Vergleichende Demethylierung von tricyclischen Psychopharmaka durch Rattenleber-Mikrosomen. Naunyn Schmiedebergs Arch Pharmacol 256: 360–366
Biggs SR, Chasseaud LF, Hawkins DR, Midgley I (1979) Determination of anitriptyline and its major basic metabolites in human urine by high-performance liquid chromatography. Drug Metab Dispos 7: 233–236
Borgå O, Garle M (1972) A gas chromatic method for the quantitative determination of nortriptyline and some of its metabolites in human plasma and urine. J Chromatogr 68: 77–88
Braithwaite RA (1976) The significance of drug interactions in the evaluation of psychottropic drugs. Br J Clin Pharmacol (Suppl) 29–34
Breyer-Pfaff U, Ewert M, Wiatr R (1978) Comparative single-dose kinetics of amitriptyline and its N-oxide in a volunteer. Arzneim Forsch (Drug Res) 28 (II): 10b, 1916–1920
Caddy B, Fish F, Tranter J (1976) Studies on the oxidation of Amitriptyline. Analyst 101: 244–254
Cassano BG, Sjöstrand SE, Hansson E (1965 a) Distribution of and fate of C14-amitriptyline in mice and rats. Psychopharmacologia 8: 1–11
Coppen A (1979) Amitriptyline and its demethylation-rate. Lancet 1: 49
Corona GL, Facino RM (1968) Identification and evaluation of amitriptyline and its basic metabolites in rabbit's urine. Biochem Pharmacol 17: 2045–2050
Eichelbaum M (1981) Polymorphism of drug oxidation in man: novel findings. Trends Pharmacol Sci 31–34
Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ (1979) Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol 16: 183–187
Eschenhof E, Rieder J (1979) Untersuchungen über das Schicksal des Antidepressivums Amitriptylin im Organismus der Ratte und des Menschen. Arzneim Forsch 19: 957–966
Gram L (1974) Metabolism of tricyclic antidepressants. Dan Med Bull 21: 218–231
Gram LF, Overø KF, Kirk L (1974) Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man. Am J Psychiatry 131: 863
Greenblatt DJ, Shader RI, Koch-Weser J (1975) Flurazepam hydrochloride, a benzodiazepine hypnotic. Ann Intern Med 83: 237
Gurney C, Roth M, Garside RF, Kerr TA, Shapira K (1972) Studies in the classification of affective disorders. Br J Psychiatry 121: 162–166
Hammar CG, Alexanderson B, Holmstedt B, Sjöqvist F (1971) Gas chromatography — mass spectrometry of nortriptyline in body fluids of man. Clin Pharmacol Ther 12: 496–505
Hammer W, Mårtens S, Sjöqvist F (1969) A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man. Clin Pharmacol Ther 10: 44–49
Hucker HB (1962) Metabolism of Amitriptyline. Pharmacologist 4: 171
Hyttel J, Christensen AV, Fjalland B (1980) Neuropharmacological properties of Amitriptyline, Nortriptyline and their metabolites. Acta Pharmacol Toxicol 47: 53–57
Knapp DR, Gaffney TE, McMahon RE, Kiplinger G (1972) Studies on human urinary and biliary metabolites of nortriptyline with stable isotope labelling. J Pharmacol Exp Ther 180: 784–790
Leenheer A de, Heyndrickx A (1971) Identification of a major metabolite or nortriptyline in human urine. J Pharm Sci 60: 1403–1405
McMahon RE, Marshall FJ, Culp HW, Miller WM (1963) The metabolism of nortriptyline N methyl 14C in rats. Biochem Pharmacol 12: 1207–1217
Mellström B, Bertilsson L, Träskman L, Rollins D, Åsberg M, Sjöqvist F (1979) Intraindividual similarity in the metabolism of Amitriptyline and chlorimipramine in depressed patients. Pharmacology 19: 282–287
Mellström B, Braithwaite R (1978) Ion pair liquid chromatography of amitriptyline and metabolites in plasma. J Chromatogr 157: 379–385
Montgomery SA, McAuley R, Rani SJ, Montgomery DB, Braithwaite RA, Dawling S (1979) Amitriptyline plasma concentration and clinical response. Br Med J 1: 230–231
Munksgaard EC (1969) Concentrations of amitriptyline and its metabolites in urine, blood and tissue in fatal amitriptyline poisoning. Acta Pharmacol (Kbh) 27: 129–134
Orme M, Breckenridge A, Brooks RV (1972) Interactions of benzodiazepines with warfarin. Br Med J 3: 611
Robinson DS, Amidon EL (1973) Interaction of benzodiazepines with warfarin. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven Press, New York, pp 641–646
Rollins DE, Alvan G, Bertilsson L, Gillette JR, Mellström B, Sjöqvist F, Träskman L (1980) Interindividual differences in amitriptyline demethylation. Clin Pharmacol Ther 28: 121–129
Santagostino G, Facino RM, Pirillo D (1974) Urinary excretion of amitriptyline N-oxide in humans. J Pharm Sci 63: 1690–1692
Silverman G, Braithwaite R (1972) Interaction of benzodiazepines with tricyclic antidepressants. Br Med J 4: 111
Silverman G, Braithwaite RA (1973) Benzodiazepines and tricyclic antidepressant plasma levels. Br Med J 3: 18–20
Sjöqvist F (1971) A pharmacokinetic approach to the treatment of depression. Int Pharmacopsychiatry 6: 147–169
Sjöqvist F, Alexanderson B, Åsberg M, Bertilson L, Borgå O, Hamberger B, Tuck D (1971) Pharmacokinetics and biological effects of nortriptyline in man. Acta Pharmacol Toxicol 29 (Suppl 3): 255–280
Sjöqvist F, Berglund F, Borgå O, Hammer W, Andersson S, Thorstrand C (1969 b) The PH dependent excretion of monomethylated tricyclic antidepressant in dog and man. Clin Pharmacol Ther 10: 826–833
Sjöqvist F, Hammer W, Borgå O, Azarnoff DL (1969 a) Pharmacological significance of the plasma level of monomethylated tricyclic antidepressants. Excerpta Med Int Congr Ser 180: 128–136
Sjöqvist F, Hammer W, Ideström CM, Lind M, Tuck D, Åsberg M (1968) Plasma levels of monomethylated tricyclic antidepressants and side effects in man. Excertpa Med Int Congr Ser 145: 246–257
Stevenson IH, Browning M, Crooks J (1972) Changes in human drug metabolism after long term exposure to hypnotics. Br Med J 4: 322–324
Swanson OA (1975) Benzodiazepines in psychiatry. S Afr Med J 49: 1829
Tillement JP (1973) Pharmacocinétique des antidépresseurs. Thérapie 28: 249–268
Vandel S, Vandel B, Sandoz M, Allers G, Bechtel P, Volmat R (1978) Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline. Eur J Clin Pharmacol 14: 185–190
Volmat R, Bechtel P, Allers G, Vandel B, Vandel S (1971) Mesure de la concentration plasmatique et effet antidépresseur de l'amitriptyline. Thérapie 32: 309–319
Whitnack E, Knapp DR, Holmes JC, Fowler NO, Gaffney TE (1972) Demethylation of nortriptyline by the dog lung. J Pharmacol Exp Ther 181: 288–291
Ziegler VE, Fuller TA, Biggs JT (1976) Nortriptyline and 10 hydroxynortriptyline plasma concentrations. J Pharm Pharmacol 28: 849–850
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vandel, B., Sandoz, M., Vandel, S. et al. Biotransformation of amitriptyline in depressive patients: Urinary excretion of seven metabolites. Eur J Clin Pharmacol 22, 239–245 (1982). https://doi.org/10.1007/BF00545222
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00545222